Fifth Third Bancorp
PRQR icon

Fifth Third Bancorp’s ProQR Therapeutics PRQR Stock Holding History

Fifth Third Bancorp’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,000
Closed -$60.6K – 4339
2025
Q4 		$60.6K Hold
30,000
– – ﹤0.01% 1388
2025
Q3 		$63.9K Buy
+30,000
New +$65.5K ﹤0.01% 1390
2021
Q2 		– Sell
-1,000
Closed -$7K – 2505
2021
Q1 		$7K Hold
1,000
– – ﹤0.01% 2111
2020
Q4 		$4K Hold
1,000
– – ﹤0.01% 2148
2020
Q3 		$5K Hold
1,000
– – ﹤0.01% 1906
2020
Q2 		$6K Buy
+1,000
New +$5.4K ﹤0.01% 1842

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Fifth Third Bancorp's PRQR Position: Q1 2026 in Review

Fifth Third Bancorp sold out of ProQR Therapeutics (PRQR) in Q1 2026, closing a stake of 30,000 shares — an estimated $60.6K sold.

Fifth Third Bancorp first reported a position in PRQR in Q2 2020 and held it in 6 quarters. The position peaked at $63.9K in Q3 2025. 69 funds tracked by Wall St. Rank hold PRQR as of Q1 2026.

  • Fifth Third Bancorp reported no remaining ProQR Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Fifth Third Bancorp sold 30,000 ProQR Therapeutics shares in Q1 2026, an estimated $60.6K.
  • Fifth Third Bancorp first reported a position in ProQR Therapeutics in Q2 2020 and held it in 6 quarters.
  • Fifth Third Bancorp's ProQR Therapeutics position peaked at $63.9K in Q3 2025.
  • 69 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.